This inventor holds 2 USPTO granted patents. Top assignee: Albert Einstein Healthcare Network. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Ierachimiel Daskal: Innovator in Cancer Research
Introduction
Ierachimiel Daskal is a notable inventor based in Elkins Park, Pennsylvania. He has made significant contributions to the field of cancer research through his innovative work. With a total of two patents to his name, Daskal is recognized for his advancements in tumor suppressor technology.
Latest Patents
Daskal's latest patents include a groundbreaking invention titled "Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof." This invention provides a novel nucleic acid molecule encoding PTX1, which has been mapped to human chromosome 12. The PTX1-encoding nucleic acid molecule, along with its encoded protein and antibodies, may be used to facilitate the diagnosis, prognosis, and treatment of cancer. This innovative approach has the potential to significantly impact cancer therapies and improve patient outcomes.
Career Highlights
Ierachimiel Daskal is affiliated with the Albert Einstein Healthcare Network, where he continues to work on advancing medical research. His dedication to improving cancer treatment through innovative solutions has established him as a key figure in his field.
Collaborations
Daskal collaborates with Simon Kwok, a fellow researcher, to further enhance the impact of their work in cancer research. Their combined efforts aim to push the boundaries of current medical knowledge and treatment options.
Conclusion
Ierachimiel Daskal's contributions to cancer research through his patents and collaborations highlight his commitment to innovation in the medical field. His work has the potential to change the landscape of cancer diagnosis and treatment, making a lasting impact on patient care.